Last Updated: May 14, 2026

Claims for Patent: 10,561,758


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,561,758
Title:Nonleaking volatile substance delivery system
Abstract:A volatile substance delivery system includes a volatile substance container to contain a volatile substance, an optional absorbent and collapsible element disposed within the container to reduce presence of undesired air during manufacture of the device, an outlet to deliver a volume of the volatile substance from the volatile substance container toward an ambient environment, and a manual screw pump to reduce volume (or sometimes, just increase pressure) within the volatile substance container and promote the delivery of the volatile substance from the volatile substance container. A safety chamber is sometimes provided to resist unintended escape of volatile substance in liquid phase to the environment.
Inventor(s):Ashok V Joshi, David J Erekson
Assignee: Microlin LLC
Application Number:US15/960,501

Details for Patent 10,561,758

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. XOLAIR omalizumab For Injection 103976 June 20, 2003 ⤷  Start Trial 2038-04-23
Genentech, Inc. XOLAIR omalizumab Injection 103976 September 28, 2018 ⤷  Start Trial 2038-04-23
Genentech, Inc. XOLAIR omalizumab Injection 103976 August 17, 2023 ⤷  Start Trial 2038-04-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.